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EDITORIAL
Renal  denervation  and  treatment-resistant
hypertension:  A  matter  of  importance  for
interventional  radiologyArterial  hypertension  is  a  very  common  condition  affecting  up  to  one  in  three  people  and
resulting  in  more  than  7  million  deaths  each  year  in  the  world.  Despite  very  considerable
progress  in  medical  treatment,  BP  objectives  (<  140/90  mmHg  as  a clinical  measurement
and  <  130/80  mmHg  in  diabetes  or  renal  impairment)  are  not  reached  in  a  signiﬁcant  num-
ber  of  hypertensive  patients  (in  France,  the  national  health/nutrition  survey  revealed  that
50  %  of  patients  of  hypertension  treated  were  not  controlled).  The  prevalence  of  hyper-
tension  resistant  to  tritherapy  including  a  diuretic  is  not  so  high,  at  approximately  8  to  12  %
in  the  general  population  of  hypertensive  patients.
Drug  treatments  are  still  not  capable  of  totally  controlling  hypertension,  and  new  instru-
mental  methods  have  appeared  recently  for  managing  resistant  cases.  At  present,  one  of
the  most  promising  is  intra-arterial  denervation  of  the  renal  artery,  which  consists  of  ablat-
ing  the  sympathetic  ﬁbres  of  the  adventitia  of  the  renal  artery.  We  do  indeed  know  that
the  sympathetic  nervous  system  that  innervates  the  kidney  via  efferent  (CNS  to  kidney)
and  afferent  (kidney  to  CNS)  ﬁbres  plays  an  important  role  in  the  long-term  homeostasis
of  arterial  pressure.  This  technique  can  be  performed  in  about  half  an  hour  under  seda-
tion/analgesia  and  has  produced  encouraging  results,  which  still  need  to  be  conﬁrmed
however,  on  a  larger  scale.
The  open,  randomised  study  published  in  the  Lancet  evaluated  the  efﬁcacy  and  safety
of  renal  denervation  for  reducing  blood  pressure  (n  =  52)  compared  with  absence  of  the
procedure  in  a  control  group  (n  =  51)  in  103  patients  with  tritherapy  resistant  hypertension
[1].  Clinical  blood  pressure  was  reduced  by  a  mean  of  32/12  mmHg  in  the  49  patients
treated  by  denervation  who  were  evaluated  after  6  months,  whereas  it  had  not  changed  in
the  51  patients  of  the  control  group  evaluated  at  6  months  (0/1  mmHg).  Even  if  there  may
have  been  bias  in  the  methodology  due  to  the  study’s  open  character  and  to  measurement
of  the  primary  evaluation  criterion  (measurement  of  clinical  blood  pressure),  the  method
should  nonetheless  be  included  in  the  therapeutic  arsenal  for  management  of  resistant
hypertension.
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You  will  ﬁnd  in  this  issue  the  multidisciplinary  consensus
ocument  (SFR-SFC)  which  describes  the  indications,  patient
election  criteria,  outlines  of  the  training  and  conditions  for
erforming  this  new  procedure,  while  awaiting  the  results
f  the  French  DENER-HTN  trial  aided  by  the  French  Ministry
f  Health  under  a  measure  to  support  innovative  and  costly
echniques  (STIC),  which  will  begin  in  May  2012.
At  present,  nobody  really  knows  what  position  this  tech-
ique  will  hold  relative  to  drug  treatment,  but  it  is  certain
hat  the  number  of  patients  who  should  be  treated  justiﬁes
he  active  involvement  of  interventional  radiologists.eference
1] Symplicity HTN-2 Investigators, Esler MD, Krum H, Sobotka PA,
Schlaich MP, Schmieder RE, et al. Renal sympathetic denervationEditorial
in patients with treatment-resistant hypertension (The Sym-
plicity HTN-2 Trial): a randomised controlled trial. Lancet
2010;376(9756):1903—9.
Marc  Sapovala,∗,  Michel  Azizi b
a Radiologie cardiovasculaire interventionnelle,
pôle imagerie informatique explorations
recherche (PIIER), hôpital européen
Georges-Pompidou, 20, rue Leblanc, 75908 Paris
cedex 15, France
b Centre d’investigation clinique, pôle imagerie
informatique explorations recherche (PIIER),
hôpital européen Georges-Pompidou,
20, rue Leblanc, 75908 Paris cedex 15, France∗ Corresponding author.
E-mail address: marc.sapoval2@egp.aphp.fr
(M. Sapoval)
